Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 19/20 | 0.39 |
| ▸ | VHL | P40337 | 1/20 | 0.36 |
| ▸ | CDK7 | P50613 | 1/20 | 0.36 |
| ▸ | CCNH | P51946 | 1/20 | 0.36 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.36 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19637619 | 0.89 | PARP1 (0.37) | KRASPARP1 | |
| SCHEMBL29493406 | 0.88 | KRAS (0.39) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL19959303 | 0.88 | KRAS (0.39) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL30007840 | 0.88 | PARP1 (0.35) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL19637840 | 0.88 | PARP1 (0.35) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL19617060 | 0.88 | PARP1 (0.35) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL19637289 | 0.87 | KRAS (0.36) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL21319823 | 0.87 | KRAS (0.45) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL31344907 | 0.87 | KRAS (0.45) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL19948062 | 0.87 | KRAS (0.36) | KRASVHLCDK7CCNHMNAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017201161-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2017-11-23 | — | — | WO | disclosed |